Hypertension, Vol 17, 619-625, Copyright © 1991 by American Heart Association
RG Woolfson and L Poston
Inhibition of active sodium transport by ouabain was found to cause
concentration- and time-dependent impairment of acetylcholine-induced
relaxation in human resistance arteries with a significant effect at 100
pM. The reduced acetylcholine response was attributable to inhibition of
the NG-monomethyl L-arginine-sensitive but not the indomethacin-sensitive
component of relaxation. Relaxation by sodium nitroprusside was not
affected by ouabain, suggesting that inhibition of sodium transport,
directly or indirectly, must affect synthesis or release of
endothelium-derived relaxing factor rather than its effector pathway. These
results do not support the existence of an additional endothelium-derived
relaxing factor other than endothelium-derived relaxing factor, which is
dependent on sodium pump activity. The finding that inhibition of sodium
transport has a profound effect on vascular relaxation may have
implications in the pathogenesis of certain forms of hypertension.
ARTICLES
Effect of ouabain on endothelium-dependent relaxation of human resistance arteries
Department of Physiology, St Thomas' Hospital, London, England.
This article has been cited by other articles:
![]() |
M. Y. Kim, G. H. Seol, G. H. Liang, J. A. Kim, and S. H. Suh Na+-K+ pump activation inhibits endothelium-dependent relaxation by activating the forward mode of Na+/Ca2+ exchanger in mouse aorta Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H2020 - H2029. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. H. Seol, S. C. Ahn, J. A. Kim, B. Nilius, and S. H. Suh Inhibition of endothelium-dependent vasorelaxation by extracellular K+: a novel controlling signal for vascular contractility Am J Physiol Heart Circ Physiol, January 1, 2004; 286(1): H329 - H339. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. C. Gonick, Y. Ding, S. C. Bondy, Z. Ni, and N. D. Vaziri Lead-Induced Hypertension : Interplay of Nitric Oxide and Reactive Oxygen Species Hypertension, December 1, 1997; 30(6): 1487 - 1492. [Abstract] [Full Text] |
||||
![]() |
H. R. Morris, A. T. Etienne, M. Panico, J. R. Tippins, J. Alaghband-Zadeh, S. M. Holland, S. Mehdizadeh, S. Jackie de Belleroche, I. Das, N. S. Khan, et al. Hypothalamic Hypertensive Factor : An Inhibitor of Nitric Oxide Synthase Activity Hypertension, December 1, 1997; 30(6): 1493 - 1498. [Abstract] [Full Text] |
||||
![]() |
M. Mohri, K. Egashira, T. Tagawa, T. Kuga, H. Tagawa, Y. Harasawa, H. Shimokawa, and A. Takeshita Basal Release of Nitric Oxide Is Decreased in the Coronary Circulation in Patients With Heart Failure Hypertension, July 1, 1997; 30(1): 50 - 56. [Abstract] [Full Text] |
||||
![]() |
C. J.J. Tack, J. A. Lutterman, G. Vervoort, T. Thien, and P. Smits Activation of the Sodium-Potassium Pump Contributes to Insulin-Induced Vasodilation in Humans Hypertension, September 1, 1996; 28(3): 426 - 432. [Abstract] [Full Text] |
||||
![]() |
A. R. Patel, T. Kurashina, J. P. Granger, and K. A. Kirchner Acute Na+,K+-ATPase Inhibition With Bufalin Impairs Pressure Natriuresis in the Rat Hypertension, March 1, 1996; 27(3): 668 - 671. [Abstract] [Full Text] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1991 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |